Navigation Links
Wound Management Technologies, Inc. Announces Conference Plans and Clinical Data Presentation at Leading Diabetic Foot Conference
Date:3/15/2010

FORT WORTH, Texas, March 15 /PRNewswire-FirstCall/ -- (OTC Bulletin Board: WNDM) Wound Management Technologies, Inc., a growing  provider of specialty medical products, announced today that its subsidiary Wound Care Innovations will exhibit at the DFCon 10 Global Diabetic Foot Conference in Los Angeles March 18-20.  Expected attendance is more than 1000 physicians, clinicians, researchers, scientists, and limb salvage experts from all 50 U.S. states and more than 42 foreign countries.  An evidence based study using their advanced wound care collagen product, CellerateRx®,  "Activated Collagen Accelerates Wound Repair and Modulates Cytokine Production in Whole Blood and PBMC Cultures" by Greg Pott, PhD, K.Scott Beard, PhD, Matthew Regulski, DPM, and Leland Shapiro, MD is one of the accepted abstracts presented at the conference.

"We are delighted to once again participate in this important conference," states Cathy Bradshaw, President of Wound Care Innovations.  "Diabetic wounds continue to be one of the most serious issues we face in health care today. Diabetes affects 24 million people in the U.S. and 189 million people worldwide and up to 25% of those will develop a foot ulcer.  We are excited about the outcomes we have seen with CellerateRx® in addressing these difficult wounds, and about the important clinical data presentation this year."

CellerateRx® patented advanced wound care collagen products are FDA cleared for all acute and chronic wounds except 3rd degree burns.

For Wound Management Technologies Shareholder Information please call 561-515-6035 or go to http://www.wmgtech.com

About Wound Care Innovations, LLC

Wound Care Innovations, LLC (WCI) is a wholly owned subsidiary of Wound Management Technologies, Inc. (OTC Bulletin Board: WNDM) with its corporate headquarters in Fort Worth, Texas, and regional offices in Ft. Lauderdale, Florida. WCI markets and distributes wound care products to the healthcare market under patented technology licensed to the Company. The Company is positioned and seeks to be a leading provider of wound care products.  For more information on CellerateRx, please visit the WCI website at www.Celleraterx.com .

About Wound Management Technologies, Inc.

Wound Management Technologies Inc's primary focus is the distribution of its unique, patented collagen product, CellerateRX®, in the $3.2B worldwide advanced wound care market, a market that is growing due to aging populations and the increase of diabetes.  Over the past 2 years WMT has focused on developing evidenced-based studies on CellerateRX and gaining physician awareness by participation in key industry conferences. Now WMT is focused on expanding sales through partnerships and contracted independent representatives. WMT has other advanced biotech products in development for bone wax, bone void fillers and shingles pain reduction as well as a subsidiary focused on eHealth technology for secure healthcare data collaboration and storage.  More information can be found on the company's websites: www.wmgtech.com, www.CellerateRX.com , and www.SecureeHealth.com .

Safe Harbor Statement:

The statements in the press release that relate to the company's expectations with regard to the future impact on the company's results from new products in development and any other statements not constituting historical facts are "forward-looking statements," within the meaning of and subject to the safe harbor created by the Private Securities Litigation Reform Act of 1995. Since this information may contain statements that involve risk and uncertainties and are subject to change at any time, the company's actual results may differ materially from expected results. This document may contain forward-looking statements concerning the Company's operations, current and future performance and financial condition. These items involve risks, contingencies and uncertainties such as product demand, market and customer acceptance, the effect of economic conditions, competition, pricing, the ability to consummate and integrate acquisitions, and other risks, contingencies and uncertainties detailed in the Company's SEC filings, which could cause the company's actual operating results, performance or business plans or prospects to differ materially from those expressed in, or implied by these statements. The Company undertakes no obligation to revise any of these statements to reflect the future circumstances or the occurrence of unanticipated events.

For Further Information:

Shareholder Relations-Communications    561-515-6035

SOURCE Wound Management Technologies, Inc.

Back to top

RELATED LINKS
http://www.wmgtech.com

'/>"/>

SOURCE Wound Management Technologies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine news :

1. Healing Wounds and Hearts: Warrior Weekend Helps Soldiers and Marines Relax and Recover
2. A novel in vitro model for light-induced wound healing
3. Wounded Soldier Who Received Historic Cell Transplant Gets Standing Ovation at Diabetes Research Institute Benefit
4. Wound-Healing Maggots Succumb to Deadly Bacteria
5. Wounded Warrior Project and Operation Touchdown 2010 Join Forces for Super Bowl XLIV
6. Wound treatment wins commercialization funds
7. Avery Dennison Innovates in Consumer Wound Care
8. LCA-Vision Joins Forces With the Wounded Warrior Project to Give the Gift of Enhanced Vision to Wounded American Heroes
9. Wounded Vets, CAREER Counselors Gather in Washington as Obama Announces Afghanistan Troop Buildup
10. Wounded Warrior Project (WWP) Applauds the Senate for Passing Crucial Family Caregiver Legislation
11. Wake Pharma US, Inc. Announces the Appointment of Kim Eldridge as Coordinator & Clinical Wound Specialist Educator
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... (PRWEB) , ... February 12, 2016 , ... ... Lean Leadership Series at Zuckerberg San Francisco General Hospital on April 5-7. The ... new behaviors and create new habits. The workshops cover a broad range of ...
(Date:2/12/2016)... NC (PRWEB) , ... February 12, 2016 , ... AssureVest ... surrounding areas, is initiating a charity drive that will raise funds earmarked to purchase ... John C. Tayloe Elementary School. , “My school is in a low-income area and ...
(Date:2/12/2016)... , ... February 12, 2016 , ... ... the Pittsburgh metro area, celebrates the beginning of the latest charity campaign in ... social skills through art. Donations to this worthy cause are currently being accepted ...
(Date:2/12/2016)... ... February 12, 2016 , ... J Thomas & Associates ... it’s commitment to act as Agents of Change in the community, announces a ... homeless families to fulfill immediate needs and help them move into permanent housing. ...
(Date:2/12/2016)... ... February 12, 2016 , ... Homeowners ... exterior design possibilities. CertainTeed, North America’s leading brand of building products, has improved ... offerings showcased in the mobile version of the ColorView® Exterior Style and Color ...
Breaking Medicine News(10 mins):
(Date:2/12/2016)... -- Memorial Hermann Health System has teamed up with Houston ... a one-of-a-kind experience to pediatric patients at Children,s ... 360-degree video and Google Cardboard, Howard was able to ... the patients and their families an unexpected, and energetically ... video . Memorial Hermann IRONMAN Sports ...
(Date:2/12/2016)... 12, 2016  Aralez Pharmaceuticals Inc. (Nasdaq: ARLZ ... Company will ring the Nasdaq Closing Bell at the ... at 4:00 p.m. ET on Tuesday, February ... Adrian Adams , will perform the honorary ... 4:00 p.m. ET.  A live webcast will be available ...
(Date:2/12/2016)... 12, 2016 --> ... Chronic Inflammation Global Clinical Trials Review, H2, 2015 ... global clinical trials landscape along with top level ... Country (G7 & E7), Trial Status, Trial Phase, ... top companies involved and enlists all trials (Trial ...
Breaking Medicine Technology: